Archive: 08/01/2019

First-in-class DNA-encoded monoclonal antibody therapy rapidly advances into the clinic

The Wistar Institute, along with partners Penn Medicine and Inovio Pharmaceuticals, Inc., announce that the FDA has approved the initiation of a first-in-human clinical trial investigating the safety and tolerability of a ...

Jan 8, 2019

Maternal programming during pregnancy induces long-term postpartum obesity

During normal pregnancy, mothers always gain body weight within a proper range. However, many women worry that extra pounds put on during pregnancy will not be lost after childbirth and, in fact, past studies have shown that ...

Jan 8, 2019

0

109

For chest pain not caused by a heart attack, doctors have a remedy

If you feel chest pain, get to a doctor fast. Nothing you're about to read below should dissuade you from that common-sense advice.

Jan 8, 2019

No, your computer probably won't blind you

About two months ago, two of my colleagues showed up to work wearing identical new glasses. When I made a joke about everyone going to see the same optometrist, I was informed that the specs were "computer glasses—over-the-counter ...

Jan 8, 2019

Dental flossing and other behaviors linked with higher levels of toxic chemicals in the body

A new study suggests certain types of consumer behaviors, including flossing with Oral-B Glide dental floss, contribute to elevated levels in the body of toxic PFAS chemicals. PFAS are water- and grease-proof substances that ...

Jan 8, 2019

3

4035

Having more than one chronic disease amplifies costs of diseases, study finds

Having two or more non-communicable diseases (multimorbidity) costs the country more than the sum of those individual diseases would cost, according to a new study published this week in PLOS Medicine by Tony Blakely from ...

Jan 8, 2019

0

1

Researcher evaluates estrogen as therapy for knee osteoarthritis

More than 30 million Americans suffer from osteoarthritis of the knee, according to the Centers for Disease Control and Prevention. The degenerative joint disease, often caused by wear and tear, is a leading cause of disability ...

Jan 8, 2019

0

2

Melanoma: dabrafenib and trametinib have added benefit

The German Institute for Quality and Efficiency in Health Care (IQWiG) investigated whether the drug combinations of dabrafenib plus trametinib and of encorafenib plus binimetinib have an added benefit in comparison with ...

Jan 8, 2019